References
- Corder AP, Jones RH, Sadler GH, Daniels P, Johnson CD. Heartburn, oesophagitis and Barrett's oesophagus in self- medicating patients in general practice. Br J Clin Pract 1996; 50: 245–8.
- Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management: the genval workshop report. Gut 1999; 44 Suppl 2:S1–16.
- Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J 1991; 302: 749–52.
- Spechler SJ. Epidemiology and natural history of gastrooesophageal reflux disease. Digestion 1992; 51 Suppl 1: S24–9.
- Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714–8.
- Galmiche JP, Scarpignato C. Esophageal ph monitoring. Functional evaluation in esophageal disease. Basel: Karger; 1994: p. 71–108.
- Johnsson F, Joelsson B, Isberg PE. Ambulatory 24-hour intraesophageal ph-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987; 28: 1145–50.
- Ott DJ, Chen YM, Gelfand DW, Munitz HA, Wu WC. Analysis of a multiphasic radiographic examination for detecting reflux esophagitis. Gastrointest Radiol 1986; 11: 1–6.
- Wu WC. Ancillary tests in the diagnosis of gastroesophageal reflux disease. Gastroenterol Clin North Am 1990; 19: 671–82.
- DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 867–76.
- Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837–47.
- Thomson AB, Chiba N, Armstrong D, Tougas G, Hunt RH. The second Canadian gastroesophageal reflux disease consensus: moving forward to new concepts. Can J Gastroenterol 1998; 12: 551–6.
- Galmiche JP, Scarpignato C. Modern diagnosis of gastroesophageal reflux disease (GERD). Hepatogastroenterology 1998; 45: 1308–15.
- Richter JE. Functional esophageal disorders. In: Drossman D, Richter JE, Talley NJ, et al. The functional gastrointestinal disorders. Boston, Mass., Little Brown & Co, Inc; 1994: p. 25–70.
- Rodriguez SL, Robinson M, Earnest D, Maton PN, Miner PB, Kleoudis C, et al. Esophageal hypersensitivity: a major cause of heartburn? Gastroenterology 1997; 112: A270.
- Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457–64.
- Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 59–66.
- Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000; 14: 389–96.
- Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro- oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15–20.
- Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997–2000.
- Lind T, Rydberg L, Kyleback A, Jonsson A, Andersson T, Hasseigren G, et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro- oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 861–7.
- Röhss K, Nilsson-Claar C, Rydholm H, Nyman L. Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg. Gastroenterology 2000; 118: A20.
- Röhss K, Wilder-Smith C, Claar-Nilsson C, Rydholm H. Esomeprazole 40 mg provides faster and more effective acid control than rabeprazole 20 mg in patients with symptoms of GERD. 9th United European Gastroenterology Week 2001.
- Wilder-Smith C, Röhss K, Lundin C, Rydholm H. Esomeprazole (e) 40 mg provides more effective acid control than pantoprazole (p) 40 mg. Gastroenterology 2000; 118: A22.
- Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal ph data. Gastroenterology 1994; 107: 1741–5.
- Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172–80.
- Kraemer HC. Evaluating medical tests: objective and quantitative guidelines. Sage Publications Inc.; 1992.
- Schindlbeck NE, Klauser AG, Voderholzer WA, Muller-Lissner SA. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995; 155: 1808–12.